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Case ReportsTranscatheter aortic valve replacement for isolated aortic valve
insufficiency: Experience with the Engager valve
Philipp Kiefer, MD, Joerg Seeburger, MD, PhD, Friedrich W. Mohr, MD, PhD, and
David M. Holzhey, MD, PhD, Leipzig, GermanySince the introduction of transcatheter aortic valve replace-
ment, numerous devices and access techniques have
beendeveloped andmodified to address the treatment of aortic
stenosis in high-risk patients.1 However, isolated aortic valve
insufficiency has remained a controversial indication.FIGURE 1. A, Transesophageal echocardiography, long axis view. B, Positio
Minn). C, Final angiographic result showing no residual aortic regurgitation.
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The Journal of Thoracic and CaWe present the case of a 72-year-old woman (body mass
index 19 kg/m2) who was admitted to our hospital because
of severe dyspnea (New York Heart Association functional
class IV). Her medical history included breast cancer
treated with mastectomy and radiotherapy followed by
surgical myoplasty in 2004. Impaired lung function with
a forced expiratory volume in 1 second of 30%, mild renal
insufficiency (creatinine 121 mmol/L), high-grade periph-
eral arterial occlusive disease, and moderate pulmonary
hypertension (pulmonary artery pressure, 51 mm Hg
plus central venous pressure) calculated her Society of
Thoracic Surgeons score and log EuroSCORE 1 as 7.2
and 25.6, respectively. Transesophageal echocardiography
revealed preserved left ventricular function (ejection frac-
tion 65%), moderate tricuspid and mitral insufficiency,
severe aortic valve insufficiency with no calcification,ning and deployment of the Engager valve (Medtronic, Inc, Minneapolis,
rdiovascular Surgery c Volume 147, Number 4 e37
Case Reportsand vena contracta of 0.6 cm (Figure 1, A). The aortic
annulus was measured at 24 mm. Preoperative computed
tomography showed an effective aortic valve annulus of
24 mm and a perimeter of 80 mm, the sinotubular size
was 35 mm, and the aortic bulge was described at 36
mm. Because of her high perioperative risk and small,
calcified femoral arteries, multidisciplinary team chose
transapical aortic valve implantation. Owing to its posi-
tioning and anchoring facilities within the aortic root,
the Engager valve (Medtronic, Inc, Minneapolis, Minn),
with a size of 26 mm was chosen for implantation. The
valve size was dependent on the annulus size, which was
determined using both transesophageal echocardiography
and computed tomography. Transapical access was
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e38 The Journal of Thoracic and Cardiovascular Surgpassing the native valve with the device, the arches were
released and placed in the coronary sinuses (Figure 1,
B). Therefore, valve embolization into the left ventricle
was almost impossible. By pulling the device slightly
toward the left ventricle, the valve was finally released
(Figure 1, C). The initial invasive measurement showed
a trace residual aortic insufficiency and a peak gradient
of 5 mm Hg. The mitral valve insufficiency immediately
decreased from grade II to III to grade I.
The patient experienced atrioventricular blockage
(grade III) and required pacemaker implantation but was
discharged on postoperative day 12.
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20-year odyssey. Arch Cardiovasc Dis. 2012;105:146-52.Direct aortic transcatheter aortic valve implantation for pure aortic
valve regurgitation after implantation of a left ventricular
assist deviceRene Krause, MD, Dietrich Metz, MD, and Hasan Bushnaq, MD, Halle, GermanyThe increasing use of continuous-flow left ventricular assist
devices (LVADs) for the purpose of destination therapy has
led to associated secondary aortic valve insufficiency (AI)
as a significant complication.1,2 Significant AI can lead to
ineffective LVAD output and end-organ malperfusion,
with consequent symptoms of congestive heart failure and
significantly worse survival.3 The management of this
condition is challenging.
CLINICAL SUMMARY
A 65-year-old woman with an LVAD was readmitted to
our heart center because of recently increased shortness of
breath at rest. The patient’s medical history included
ischemic cardiomyopathy, chronic obstructive pulmonary
disease, pulmonary hypertension, moderate impaired renal
function, and type II diabetes mellitus. Because of theend-stage ischemic cardiomyopathy with terminal heart
failure (New York Heart Association class IV), she had un-
dergone an LVAD implantation (HeartMate II; Thoratec
Corporation, Pleasanton, Calif) from the left ventricular
apex to the ascending aorta through a sternotomy in
December 2009 (Figure 1).
Thereafter the patient recovered to a good general status.
During the routine follow-ups in 2012, she reported
increasing shortness of breath at daily activities. Echocardi-
ography showed at this time a new finding of AI of grade II.
Despite optimal medical therapy and LVAD adjustments,
her symptoms remained. The repeated echocardiography
after emergency admission showed moderate AI with vol-
ume overload of the left side of the heart as a result of a
continuous AI during systole and diastole (Figure 2). The
cusps and the annulus showed a mild degeneration as well
as an altered coapting function. LVAD function was
completely accurate. During hospitalization with optimal
medical treatment, the patient’s condition gradually deteri-
orated. She was therefore submitted for surgical treatment
of the AI.
Because of the patient’s poor general status, the multi-
morbidity and conducted heart surgery, we decided to
attempt transcatheter aortic valve implantation (TAVI).
The direct aortic access was chosen because of our previous
good experiences with this procedure. In this case, it pro-
vided some advantages to the femoral access.ery c April 2014
